Mixed Salts of a Single Entity Amphetamine Product XR 3.75 mg/1

Active Ingredient:: Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetam
Form:: CAPSULE, EXTENDED RELEASE
Brand:: Mixed Salts of a Single Entity Amphetamine Product XR
Origin:: USA

Mixed Salts of a Single Entity Amphetamine Product XR 3.75 mg/1 (Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetam CAPSULE, EXTENDED RELEASE) 3.75 mg/1

Mixed Salts of a Single Entity Amphetamine Product XR 3.75 mg/1 is an extended-release capsule designed for oral use. It contains a blend of amphetamine salts, commonly used for attention deficit hyperactivity disorder (ADHD) management. This medication is manufactured by SpecGx LLC in the USA.

Strength

3.75 mg/1

Pack Size

100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0406-8953-01)

Manufacturer / TM Owner

SpecGx LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Mixed Salts of a Single Entity Amphetamine Product XR 3.75 mg/1 is primarily used for the treatment of ADHD. The extended-release formulation is designed to provide a steady release of the active ingredients over time. This medication is often prescribed to help improve focus, attention, and impulse control in individuals with ADHD. What is Mixed Salts of a Single Entity Amphetamine Product XR used for? It is typically used as part of a comprehensive treatment plan that may include behavioral therapy and other interventions.

Side Effects

Common effects of Mixed Salts of a Single Entity Amphetamine Product XR 3.75 mg/1 may include increased alertness, improved concentration, and reduced hyperactivity. Some individuals may experience side effects such as decreased appetite, insomnia, or mild stomach upset. The extended-release formulation is designed to minimize fluctuations in drug levels, which can help reduce the likelihood of side effects.

Precautions & Warnings

Mixed Salts of a Single Entity Amphetamine Product XR 3.75 mg/1 should be handled with care and stored securely to prevent misuse. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. This medication should not be shared with others, even if they have similar symptoms. Always consult a healthcare provider before starting or stopping any medication.

Avoid Interactions

Mixed Salts of a Single Entity Amphetamine Product XR 3.75 mg/1 may interact with certain medications, including other stimulants, antidepressants, and medications that affect blood pressure. Alcohol and other central nervous system depressants may also interact with this medication. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

It is primarily used for the management of ADHD, helping to improve focus and attention.

It is designed for oral use and should be taken as directed by a healthcare professional.

Common side effects may include decreased appetite, insomnia, and mild stomach upset.

It may interact with certain medications, so it is important to consult a healthcare provider before combining with other drugs.

Long-term use should be monitored by a healthcare professional to ensure safety and effectiveness.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.